A nanocomposite competent to overcome cascade drug resistance in ovarian cancer via mitochondria dysfunction and NO gas synergistic therapy
Open Access
- 30 November 2023
- journal article
- research article
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 18 (6) , 100872
Abstract
No abstract availableKeywords
Funding Information
- Southern Medical University (YM202202)
- Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515011050)
This publication has 57 references indexed in Scilit:
- Reactive oxygen species, cellular redox systems, and apoptosisFree Radical Biology and Medicine, 2010
- SnapShot: Reactive Oxygen Intermediates (ROI)Cell, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and CarboplatinClinical Cancer Research, 2009
- Is Glutathione the Major Cellular Target of Cisplatin? A Study of the Interactions of Cisplatin with Cancer Cell ExtractsJournal of Medicinal Chemistry, 2009
- Mitochondria and Reactive Oxygen SpeciesHypertension, 2009
- Nitric Oxide and Peroxynitrite in Health and DiseasePhysiological Reviews, 2007
- Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and ApoptosisScience, 2004
- Mitochondrial formation of reactive oxygen speciesThe Journal of Physiology, 2003
- Overexpression of glutathione S-transferase π enhances the adduct formation of cisplatin with glutathione in human cancer cellsFree Radical Research, 1999